Boone Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Boone Capital Management's AMGN Position: Q1 2024 in Review
Boone Capital Management sold out of Amgen (AMGN) in Q1 2024, closing a stake of 101,508 shares — an estimated $29.2M sold.
Boone Capital Management first reported a position in AMGN in Q1 2023 and held it in 4 quarters. The position peaked at $29.2M in Q4 2023. 2,716 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.
- Boone Capital Management reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
- Boone Capital Management sold 101,508 Amgen shares in Q1 2024, an estimated $29.2M.
- Boone Capital Management first reported a position in Amgen in Q1 2023 and held it in 4 quarters.
- Boone Capital Management's Amgen position peaked at $29.2M in Q4 2023.
- 2,716 funds tracked by Wall St. Rank held Amgen as of Q1 2024.
Based on Boone Capital Management's 13F filing for Q1 2024, filed 15 May 2024.